Contemporary issues in the surgical management of pancreatic neuroendocrine tumours

Pancreatic neuroendocrine tumours (PNET) are relatively rare entities, accounting for 1–2 per cent of pancreatic neoplasms. However, rates of diagnosis have recently increased, in part due to incidental discovery on the widespread use of cross‐sectional imaging. While general consensus exists regarding the treatment of large and/or functional PNET, the management of smaller (<2 cm) asymptomatic lesions is less clear. Recent updates in staging...